The Women's Recovery Group Study: Stage I Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Alcohol-Related DisordersSubstance-Related Disorders
Interventions
BEHAVIORAL

The Women's Recovery Group

The Women's Recovery Group (WRG) is a manual-based group therapy for women heterogeneous with respect to their substance use disorder, co-occurring psychiatric disorders, trauma history, age, and stage of life. The WRG is a 12-session, structured relapse-prevention group therapy that utilizes a cognitive behavioral approach and includes gender-specific content and single-gender group composition. Individual session content was derived from research on gender-specific substance abuse antecedents, consequences, and treatment outcomes. The overall goals of the treatment are to (1) promote abstinence from all substances including alcohol; (2) improve understanding of specific aspects of SUDs, recovery, and relapse that are relevant to women, and (3) help participants with skills and strategies useful in preventing relapse and promoting recovery.

BEHAVIORAL

mixed-gender Group Drug Counseling

Group Drug Counseling (GDC) is a standard 12-week, 90-minute mixed-gender group therapy. The overall goals of GDC are to 1) help patients to achieve abstinence from all substances of abuse; 2) educate patients regarding recovery from substance use disorders; 3) increase patients' self-awareness of the problems that their substance use disorder has caused; 4) encourage patients to give mutual support; and 5) help patients learn new ways to cope with problems in order to prevent relapse. The GDC was chosen as the comparison group to approximate group drug counseling that is consistent with treatment as usual within the community.

Trial Locations (1)

02478 9106

McLean Hospital, Belmont

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Mclean Hospital

OTHER

NCT00230100 - The Women's Recovery Group Study: Stage I Trial | Biotech Hunter | Biotech Hunter